Tevogen Bio Holdings Inc. announced the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development. Mr. Shah, a Wall Street veteran with over 25 years of experience across key financial services industry verticals, brings broad leadership capabilities to Tevogen Bio. Most recently, Mr. Shah was Director, Relationship Management, in Citigroup?s Client organization, where he was also a member of the Executive Office.

Prior to Citigroup, he worked in Morgan Stanley?s asset management business (MSIM) focused on Equity Strategy and Product Development. Mr. Shah started his career in the Investment Banking Division of Goldman Sachs. In this new position, Mr. Shah will lead communications with all financial stakeholders including shareholders, lenders, research analysts, and investment bankers.

He will also lead the M&A and capital raising functions at Tevogen Bio and be responsible for consolidating and analyzing inputs from key internal stakeholders to advise the executive leadership team on an appropriate course of action. Mr. Shah will report directly to Tevogen Bio?s Founder and Chief Executive Officer, Dr. Ryan Saadi. Mr. Shah completed a bachelor?s degree in mathematics from New York University?s Courant Institute of Mathematical Sciences and certified post-graduate programs at Harvard Business School.